In Pacemakers, A new Battle Breaks Out
The pacemaker and defibrillator industries have been marked by dozens of patent suits and settlements over the years. Now, Medtronic Inc., St. Jude and Sulzer Intermedics are back in court, claiming tortious interference--specifically, that each is trying to steal the others' sales reps.
You may also be interested in...
ABHI’s Phil Brown looks beyond the immediate challenges for UK medtechs on being outside the EU, and to an innovation-friendly, patient-responsive system of future regulation.
For a biotech launching its first product the pandemic has compounded the usual pressures of a competitive indication against deeper-pocketed competition.
Following Mylan’s initial launch of a generic rival to Biogen’s $3.8bn Tecfidera brand, other generics companies are now following the firm into the US dimethyl fumarate market.